DWF Advises Algebris Investments on Investment in Biocentis

"DWF advised Algebris Investments and Bird & Bird (London) advised Biocentis on a €19 million funding round in Biocentis, a spin‑off of Imperial College London developing precision genetic solutions to reduce pest fertility and replace chemical pesticides. The investment is Algebris Investments’ third in 2025 and supports its strategy backing European deeptech with CO2 reduction impact."

DWF advised Algebris Investments, while Bird & Bird’s London office advised Biocentis in the transaction. The transaction involved a €19 million investment round in Biocentis, a pioneering life sciences company that develops next‑generation genetic solutions for sustainable pest control in agriculture and beyond. Founded as an innovative spin‑off of Imperial College London with offices in London and Milan, Biocentis has developed a platform based on precision genetic engineering techniques to reduce the fertility of harmful insect populations, aiming to replace chemical pesticides with biological methods and contribute to the reduction of indirect emissions in the agricultural sector. With this investment, which is Algebris Investments’ third completed in 2025, the investor consolidates its strategy of supporting European deeptech technologies with a direct impact on CO2 reduction. DWF represented Algebris Investments with a team composed by: partner Antonio Ferri and associate Federica Boscolo. Bird & Bird (London office) represented Biocentis with a team composed by: partner James Baillieu, senior associate Sarah Bratton‑Bishop and associate Kimberly Tan.

DWF Advises Algebris Investments on Investment in Biocentis

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads